Ashuai Du

848 total citations · 1 hit paper
12 papers, 275 citations indexed

About

Ashuai Du is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ashuai Du has authored 12 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Ashuai Du's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (3 papers). Ashuai Du is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and Circular RNAs in diseases (3 papers). Ashuai Du collaborates with scholars based in China and United States. Ashuai Du's co-authors include Qinglong Yang, Yuzheng Zhou, Zanxian Xia, Cyrollah Disoma, Shiqin Li, Aroona Razzaq, Zijun Dong, Pinjia Liu, Zongpeng Chen and Yuxin Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Ashuai Du

11 papers receiving 274 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma

2022 145 citations Ashuai Du, Shiqin Li et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashuai Du China	6	219	156	33	23	23	12	275
Joshua Victor United States	4	260 1.2×	155 1.0×	37 1.1×	21 0.9×	25 1.1×	4	314
Assunta Sellitto Italy	11	237 1.1×	90 0.6×	51 1.5×	25 1.1×	20 0.9×	12	325
Haili Gao China	7	284 1.3×	250 1.6×	31 0.9×	14 0.6×	36 1.6×	20	364
Hu Ma China	9	193 0.9×	168 1.1×	69 2.1×	42 1.8×	29 1.3×	23	292
Lichong Yan China	7	345 1.6×	218 1.4×	25 0.8×	16 0.7×	33 1.4×	9	401
Hongjuan Cui China	9	157 0.7×	65 0.4×	27 0.8×	29 1.3×	38 1.7×	17	234
Shachar Raz Israel	7	206 0.9×	78 0.5×	99 3.0×	15 0.7×	19 0.8×	7	311
Shimeng Pan China	5	311 1.4×	257 1.6×	27 0.8×	18 0.8×	33 1.4×	6	348
Rim Jawad Wiklander Sweden	8	245 1.1×	117 0.8×	17 0.5×	16 0.7×	24 1.0×	9	295

Countries citing papers authored by Ashuai Du

Since Specialization

Citations

This map shows the geographic impact of Ashuai Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashuai Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashuai Du more than expected).

Fields of papers citing papers by Ashuai Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashuai Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashuai Du. The network helps show where Ashuai Du may publish in the future.

Co-authorship network of co-authors of Ashuai Du

This figure shows the co-authorship network connecting the top 25 collaborators of Ashuai Du. A scholar is included among the top collaborators of Ashuai Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashuai Du. Ashuai Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Xu, Rong, Ashuai Du, Xinpei Deng, et al.. (2024). tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB. Journal of Experimental & Clinical Cancer Research. 43(1). 230–230. 29 indexed citations

2.

Du, Ashuai, et al.. (2024). Exploration of shared gene signatures and molecular mechanisms between type 2 diabetes and osteoporosis. Journal of Cellular and Molecular Medicine. 28(9). e18141–e18141.

3.

Du, Wei, et al.. (2024). Bidirectional crosstalk between the epithelial-mesenchymal transition and immunotherapy: A bibliometric study. Human Vaccines & Immunotherapeutics. 20(1). 2328403–2328403. 4 indexed citations

4.

Du, Wei, et al.. (2024). ITGB2 related to immune cell infiltration as a potential therapeutic target of inflammatory bowel disease using bioinformatics and functional research. Journal of Cellular and Molecular Medicine. 28(15). e18501–e18501. 3 indexed citations

5.

Du, Ashuai, et al.. (2023). m6A‐related lncRNAs as potential biomarkers and the lncRNA ELFN1‐AS1/miR‐182‐5p/BCL‐2 regulatory axis in diffuse large B‐cell lymphoma. Journal of Cellular and Molecular Medicine. 28(2). e18046–e18046. 4 indexed citations

6.

Du, Ashuai, Qinglong Yang, Xiaoying Sun, & Qiangqiang Zhao. (2023). Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression. International Immunopharmacology. 124(Pt A). 110868–110868. 26 indexed citations

7.

Du, Ashuai, et al.. (2023). Cuproptosis-related lncRNAs as potential biomarkers of AML prognosis and the role of lncRNA HAGLR/miR-326/CDKN2A regulatory axis in AML.. PubMed. 13(9). 3921–3940. 2 indexed citations

8.

Du, Ashuai, Shiqin Li, Yuzheng Zhou, et al.. (2022). M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Molecular Cancer. 21(1). 109–109. 145 indexed citations breakdown →

9.

Xu, Rong, Xin Wu, Ashuai Du, Qiangqiang Zhao, & He Huang. (2022). Identification of cuproptosis-related long non-coding ribonucleic acid signature as a novel prognosis model for colon cancer.. PubMed. 12(11). 5241–5254. 4 indexed citations

10.

Du, Ashuai, et al.. (2021). m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia. Frontiers in Immunology. 12. 789914–789914. 25 indexed citations

11.

Li, Shiqin, Sijia Li, Cyrollah Disoma, et al.. (2020). SARS‐CoV‐2: Mechanism of infection and emerging technologies for future prospects. Reviews in Medical Virology. 31(2). e2168–e2168. 19 indexed citations

12.

Disoma, Cyrollah, Yuzheng Zhou, Zongpeng Chen, et al.. (2019). Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS. Biochemical and Biophysical Research Communications. 513(3). 746–752. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact